16 unknown. 16 Phase 3, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 16 | Unknown 16 |
| Phase 2 | 8 | Unknown 8 |
Follow Neurodevelopmental Disorders: new trials by email Literature Review of Neurodevelopmental Disorders trials Research Report on Neurodevelopmental Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of MAD as add-on Therapy in Comparison With Standard of Care in Children With ASD Modified Atkin's Diet with standard of care, Standard of Care - Modified Atkins Diet, Autism Spectrum Disorder | Phase 2 / Phase 3 | Unknown | All India Institute of Medical Sciences | 80 | 2024-03-20 | 2024-03-18 |
| Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD Behavior therapy, Psychoeducation - Autism Spectrum Disorder | Phase 2 / Phase 3 | Unknown | Stanford University | 90 | 2024-01-05 | 2024-08-27 |
| Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill Treadmill workstation, Methylphenidate - Attention Deficit Disorder | Phase 2 / Phase 3 | Unknown | Ariel University | 30 | 2021-10-01 | 2022-03-31 |
| Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension - Autism Spectrum Disorder, Sleep Disorder | Phase 3 | Unknown | Vanda Pharmaceuticals | 100 | 2021-07-28 | 2024-03-21 |
| Melatonin as Adjuvant Treatment for ADHD in Adults Melatonin 5 mg - Attention Deficit Hyperactivity Disorder | Phase 3 | Unknown | Hospital Israelita Albert Einstein | 120 | 2017-09-01 | 2018-08-15 |
| Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering). Ecopipam 50mg, Ecopipam 100mg - Stuttering, Adult, Childhood-onset Fluency Disorder | Phase 2 / Phase 3 | Unknown | Gerald Maguire, MD | 10 | 2016-09-01 | 2016-10-26 |
| Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex Everolimus, Placebo - Tuberous Sclerosis Complex, TSC Related Cognitive Disability | Phase 2 / Phase 3 | Unknown | Erasmus Medical Center | 60 | 2012-11-01 | 2015-05-05 |
| Clinical and Cost Effectiveness of Positive Behaviour Support: a Trial PBS based staff training, Treatment as Usual - Challenging Behaviour | Phase 3 | Unknown | University College, London | 246 | 2012-11-01 | 2016-05-23 |
| Group Psychoeducational Program for Mothers of Children With High Functional Pervasive Developmental Disorders Family psychoeducational therapy plus TAU, Treatment as usual - Pervasive Developmental Disorder | Phase 2 / Phase 3 | Unknown | Nagoya City University | 74 | 2010-09-01 | 2011-01-19 |
| Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy Atomoxetine, Sugar Pill - Attention Deficit Disorder With Hyperactivity | Phase 3 | Unknown | University of Cincinnati | 120 | 2009-09-01 | 2015-08-19 |
| Randomized Clinical Trial of Phonological Interventions Speech Production Intervention, Speech Perception Intervention, Articulation Parent Group - Speech Articulation Disorder, Developmental Articulation Disorder | Phase 2 / Phase 3 | Unknown | McGill University | 96 | 2008-11-01 | 2009-09-23 |
| Enhancing Self-Understanding and Social Integration of Middle School Students With Learning Disabilities Group treatment - Learning Disability | Phase 2 / Phase 3 | Unknown | University of Toronto | 2004-09-01 | 2006-02-17 | |
| Self-Injury: Diagnosis and Treatment Naltrexone hydrochloride, Transcutaneous sensory nerve stimulation - Self-Injurious Behavior, Mental Retardation | Phase 3 | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 37 | 1997-07-01 | 2005-06-24 |
| Repetitive Behavior Disorders in People With Severe Mental Retardation sertraline - Mental Retardation, Stereotyped Behavior | Phase 3 | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1992-09-01 | 2007-06-26 | |
| Magnesium Sulfate to Prevent Brain Injury in Premature Infants magnesium sulfate - Brain Injuries, Cerebral Palsy | Phase 3 | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1987-08-01 | 2005-06-24 | |
| Valproate Response in Aggressive Autistic Adolescents Valproate - Autism | Phase 3 | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 30 | 2005-06-24 |
Intellectual Disability (5) · Attention Deficit Disorder with Hyperactivity (3) · Autism Spectrum Disorder (3) · Autistic Disorder (2) · Communication Disorders (2) · Self-Injurious Behavior (2) · Articulation Disorders (1) · Brain Injuries (1) · Cerebral Palsy (1) · Child Development Disorders, Pervasive (1) · Childhood-Onset Fluency Disorder (1) · Compulsive Behavior (1) · Developmental Disabilities (1) · Dyslexia (1) · Intracranial Hemorrhages (1)
Mental Disorders (16) · Neurologic Manifestations (9) · Pathological Conditions, Signs and Symptoms (9) · Signs and Symptoms (9) · Nervous System Diseases (8) · Neurobehavioral Manifestations (8) · Child Development Disorders, Pervasive (5) · Attention Deficit and Disruptive Behavior Disorders (3) · Autism Spectrum Disorder (2) · Behavior (2) · Behavioral Symptoms (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Brain Damage, Chronic (1) · Brain Diseases (1)
Therapeutics (2) · Atomoxetine Hydrochloride (1) · Behavior Therapy (1) · Everolimus (1) · Magnesium Sulfate (1) · Melatonin (1) · Methylphenidate (1) · Naltrexone (1) · Sertraline (1) · Standard of Care (1) · Sugars (1) · Valproic Acid (1) · ecopipam (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (4) · All India Institute of Medical Sciences (1) · Ariel University (1) · Erasmus Medical Center (1) · Gerald Maguire, MD (1) · Hospital Israelita Albert Einstein (1) · McGill University (1) · Nagoya City University (1) · Stanford University (1) · University College, London (1) · University of Cincinnati (1) · University of Toronto (1) · Vanda Pharmaceuticals (1)
United States (8) · Canada (2) · Brazil (1) · Israel (1) · Japan (1) · Netherlands (1) · United Kingdom (1)
Andre Strydom, MD PhD (1) · Faye Mishna, PhD (1) · Floyd R Sallee, MD (1) · Frank Symons, Ph.D. (1) · Ian Hall, MBBS MPhil (1) · Jessica A. Hellings, M.D. (1) · Liat Korn, PhD (1) · Mark Lewis, PhD (1) · Masako Suzuki, MD (1) · Michael King, FRCGP PhD (1) · Rachael Hunter (1) · Rumana Omar (1) · Sheffali Gulati, MD (1) · Susan Rvachew, Ph.D. (1)
PMID 10917410, PMID 12849360, PMID 15026214, PMID 15212606, PMID 15328899, PMID 20075648, PMID 24434529, PMID 29436314, PMID 29596045, PMID 31217257, PMID 32019635, PMID 32293383, PMID 42190642
K08MH001516 (1), R01HD021453 (1), R01MH081854 (1)